Prasugrel 60 mg

DRUG3 trials

Sponsors

Eli Lilly and Company, Dong-A University

Conditions

Acute Coronary SyndromeCoronary ArteriosclerosisCoronary Artery DiseaseST-Segment Elevation Myocardial Infarction

Phase 2

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event

CompletedNCT00356135

Eli Lilly and CompanyAcute Coronary Syndrome, Coronary Arteriosclerosis

Start: 2006-07-31End: 2008-12-31Updated: 2010-11-03

Phase 3

Prasugrel With Lower Dose - Loading Dose

CompletedNCT02070159

Dong-A UniversityCoronary Artery Disease

Start: 2011-12-31End: 2013-01-31Updated: 2014-02-25

Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction

TerminatedNCT02075125

Dong-A UniversityST-Segment Elevation Myocardial Infarction

Start: 2014-01-31End: 2015-04-30Updated: 2017-08-18

Related Papers

Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction

Circulation Journal2015-01-0122 citations

Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study.

2010-09-01123 citations